Showing 8,161 - 8,180 results of 20,793 for search '"Therapy"', query time: 0.13s Refine Results
  1. 8161

    Balanced crystalloid versus saline for resuscitation in pediatric septic shock: a systematic review and meta-analysis by Barkhá Vijendra, Ana Beatriz Bertol, Mylena Maria Guedes de Almeida, Pedro Henrique Aquino Gil de Freitas, Áurea Maria Salomão Simão, Bianca Lisa de Faria

    Published 2025-01-01
    “…However, the need for renal replacement therapy was significantly less frequent in patients treated with BS compared to NS (RR 0.58; 95% CI 0.39 to 0.87; p = 0.008; I² = 0%). …”
    Get full text
    Article
  2. 8162

    Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease by V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, T. L. Lapina, O. A. Storonova, O. V. Zayratyants, O. B. Dronova, Yu. A. Kucheryavyy, S. S. Pirogov, R. G. Sayfutdinov, Yu. P. Uspenskiy, A. A. Sheptulin, D. N. Andreev, D. E. Rumyantseva

    Published 2020-09-01
    “…Current recommendations of the Russian Gastroenterological Association are developed to acquaint medical practitioners with modern diagnostics, treatment and trends in rational drug therapy for gastroesophageal reflux disease (GERD).General provisions. …”
    Get full text
    Article
  3. 8163
  4. 8164

    World-wide survey on the treatment of peripheral vestibular disorders by Michael Strupp, Michael Strupp, Nils Lucca Kern, Nils Lucca Kern, Göran Laurell, Louisa Lehner, Eva Grill, Eva Grill, Ralf Strobl, Ralf Strobl

    Published 2025-02-01
    “…ObjectiveThe aim of this world-wide survey was to evaluate the currently applied treatment options for the six most frequent peripheral vestibular disorders: benign paroxysmal positional vertigo (BPPV), acute unilateral vestibulopathy (AUVP)/vestibular neuritis, Menière’s disease (MD), bilateral vestibulopathy (BVP), vestibular paroxysmia (VP) and superior canal dehiscence syndrome (SCDS).BackgroundFor the therapy of vestibular disorders, there are four treatment options: vestibular physical therapy (canalith repositioning maneuvers or balance training), pharmacotherapy, surgery, and psychotherapy. …”
    Get full text
    Article
  5. 8165

    Helicobacter pylori infection at long-term treatment by proton pump inhibitors for acid-related diseases (Literature review and resolution of Advisory council, March 22, 2018) by V. T. Ivashkin, I. V. Mayev, R. A. Abdulkhakov, O. P. Alekseyeva, S. A. Alekseyenko, A. Yu. Baranovsky, Ye. K. Baranskaya, I. L. Klyaritskaya, N. V. Korochanskaya, Yu. A. Kucheryavy, T. L. Lapina, M. F. Osipenko, V. I. Simanenkov, G. N. Tarasova, A. S. Trukhmanov, I. B. Khlynov, A. A. Sheptulin

    Published 2018-08-01
    “…Testing for H. pylori infection and carrying out the subsequent eradication therapy could allow to prevent progression of corpus mucosa atrophy in patients with acid-related disorders, first of all those with GERD, who received long-term PPI treatment. …”
    Get full text
    Article
  6. 8166

    Effect of Rehabilitation Robot Combined with Upper Limb Rehabilitation Training on Hemiplegic Patients in Recovery Stage of Stroke by LI Yuqi, HUANG Guozhi, LU Pengcheng, HE Longlong, HUANG Wenhao, HUANG Chuhong, ZENG Qing

    Published 2022-04-01
    “…Both groups received basic medication and conventional rehabilitation therapy (including good limb position, active and passive joint movement, sitting and standing balance training, walking function training, assistive device use training, speech and swallowing therapy, conventional physical therapy, etc.). …”
    Get full text
    Article
  7. 8167
  8. 8168

    The effect of repetitive transcranial magnetic stimulation on sleep quality in patients with more than mild depressive mood: a systematic review and meta-analysis by Yu’ang Liu, Silang Huang, Xinxin Zhang, Huangying Liao, Weiguo Liu, Zhi Zhang, Xianhui Qu, Ziwen Wang

    Published 2025-02-01
    “…In terms of whether combination therapy was used or not, compared with the combination therapy group (I2 = 29%, MD = −1.39, 95%CI = −2.30 to −0.48, p = 0.003), the non-combination therapy group had a better treatment effect (I2 = 0%, MD = −2.93, 95%CI = −3.36 to −2.50, p < 0.00001).ConclusionrTMS significantly improves sleep quality in patients with more than mild depression. …”
    Get full text
    Article
  9. 8169
  10. 8170
  11. 8171
  12. 8172

    Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer by Satoshi Endo, Hisao Imai, Atsuto Mouri, Kasumi Tsukamoto, Kenji Masaki, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Junichi Nakagawa, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu

    Published 2025-01-01
    “…Abstract Purpose Nivolumab plus ipilimumab (Nivo-Ipi) combination therapy is an effective first-line treatment for advanced non-small cell lung cancer (NSCLC). …”
    Get full text
    Article
  13. 8173
  14. 8174

    Intravenous Laser Blood Irradiation and Tocilizumab in a Patient with Juvenile Arthritis by Dragos Andrei Chiran, Michael Weber, Laura Marinela Ailioaie, Eovelina Moraru, Constantin Ailioaie, Daniela Litscher, Gerhard Litscher

    Published 2014-01-01
    “…When ILBI was introduced, the patient was receiving disease-modifying drugs, steroids, tocilizumab, and physical therapy. Because the disease was not well controlled, ILBI was applied in addition to other ongoing therapies. …”
    Get full text
    Article
  15. 8175

    Effect of Sustained Translatory Joint-play Techniques Combined with Stretching Technique on Shoulder Dysfunction after Rotator Cuff Injury by Mingliang JIN, Hua YUAN, Xiang MU, Qiang DUAN, Xu HU, Zhongqi LU

    Published 2018-06-01
    “…The control group accepted converser treatment including tepid magnetic vibration therapy, lower power He-Ne laser therapy, range of motion exercise, shoulder muscle strengthen exercise, rotator cuff muscle strengthen exercise, Maitland joint mobilization and cold therapy, once a day,6 days per week, lasted for four weeks. …”
    Get full text
    Article
  16. 8176

    Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis by Sandra Lilliebladh, Åsa Johansson, Åsa Pettersson, Sophie Ohlsson, Thomas Hellmark

    Published 2018-01-01
    “…In this study, different CD4+ T cell populations in patients with AAV were analysed and compared to healthy blood donors as well as therapy controls. 18 patients with active AAV, 46 in remission, 21 healthy controls (HBD), and 15 therapy controls (TC) were enrolled. …”
    Get full text
    Article
  17. 8177

    Contribution of Statins towards Periodontal Treatment: A Review by Catherine Petit, Fareeha Batool, Isaac Maximiliano Bugueno, Pascale Schwinté, Nadia Benkirane-Jessel, Olivier Huck

    Published 2019-01-01
    “…Herein, the adjunctive use of statins in periodontal therapy in vitro, in vivo, and in clinical trials was reviewed. …”
    Get full text
    Article
  18. 8178

    National trends in treatments for ectopic pregnancy in Japan from 2010 to 2020: a retrospective observational study by Risa Ishida, Hiroyuki Ohbe, Gentaro Izumi, Daisuke Shigemi, Hiroki Matsui, Kaori Koga, Hideo Yasunaga, Yutaka Osuga

    Published 2024-12-01
    “…Regarding methotrexate use for the site of the pregnancy, there was a significant downward trend in methotrexate therapy for tubal pregnancies. Notably, the methotrexate success rate was 84% during the study period.Conclusions Surgery showed an increasing tendency over time, whereas methotrexate therapy showed a decreasing tendency for EP treatment in Japan. …”
    Get full text
    Article
  19. 8179

    Comparative Analysis of Periapical Healing and Periodontal Health in Endodontically Treated Teeth with Different Obturation Techniques by Mayur Kahate, Rakhi Rajendran, Urvashi A. Shetty, Sufia Parveen, Ashtha Arya, Hanadi A. Alwafi

    Published 2024-12-01
    “…Background: The goals of endodontic therapy are to eradicate infection and encourage periapical tissue repair. …”
    Get full text
    Article
  20. 8180

    Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease by Daisuke Fukamachi, Yasuo Okumura, Naoya Matsumoto, Eizo Tachibana, Koji Oiwa, Makoto Ichikawa, Hironori Haruta, Kazumiki Nomoto, Ken Arima, Atsushi Hirayama

    Published 2022-01-01
    “…It might be possible to shorten the time for de-escalation from a dual therapy to monotherapy, but data regarding de-escalation to an edoxaban monotherapy are lacking. …”
    Get full text
    Article